AI in Medicine News — 2026-11-03 (Tue)

Overview

Hospital operations and accountability drew the most coverage, including a Guardian report on little-used Palantir technology at NHS trusts and several pieces on accountability for medical AI. Diagnostics, drug discovery, and records tools also moved, and Japan's PMDA published guidance on AI use in regulatory activities. None of the headlines gives outcome evidence beyond a few study-level results.

Diagnostics and imaging

- A focused review and framework covers generative AI in clinical reasoning education. It is a review, not a performance study (Cureus). - TCT 2026 clinical data show an 84% reporting gap in aortic valve calcification. The headline says this highlights the potential of Nanox.AI's AVC solution, and it does not give the product's accuracy (Taiwan News). - A systematic review compares AI with human interpretation in diagnostic radiology, looking at diagnostic accuracy and operational efficiency. The headline gives no results (Cureus). - BMH and DeepInfinity.AI are partnering to scale healthcare AI. This is a partnership announcement (ET Edge Insights). - Thailand is moving to advance AI-powered cancer diagnosis. No performance figures are given (Thai PBS World).

Clinical decision support

- A Medscape piece says AI helps but GPs know what really matters to patients (Medscape). - A Yahoo Finance Singapore piece asks what Doximity is building with its new AI dosing tool. The headline gives no performance or validation details (Yahoo Finance Singapore). - A market report covers AI in sepsis warning systems for 2026-2033. It is market research, not clinical evidence (Grand View Research). - A 2026 academic conference on AI agent-enabled digital laboratory medicine was held in Shanghai (SHINE). 【Generative AI and clinical documentation】 - Athenahealth launched a tool to bring patient health records into Anthropic's Claude (Fierce Healthcare). - A Stony Brook study says AI may improve patient discharge summaries. The headline gives no study design or results (Stony Brook Medicine). 【Hospital operations and care delivery】 - A new 2027 outlook says hospital AI funding faces a reality check and puts outsourcing savings to the test (The Batesville Daily Guard). - Palantir AI technology is unused or little used by 29 NHS trusts said to be benefiting from it (The Guardian). - An AI chief says treating medical AI as new is a real danger. The headline does not name the person (Newsweek). - An opinion piece on how AI could trigger a national crisis cites frozen bank accounts, NHS errors, and food shortages (The European Magazine). - A Healthcare Management Magazine piece is headlined Keeping AI accountable (Healthcare Management Magazine). 【Drug discovery and clinical trials】 No headline states a development stage (preclinical, Phase I, etc.). - A piece asks whether AI can redesign mRNA to last weeks rather than days. It is framed as a question (Drug Discovery News). - Regina Barzilay and Jim Collins won the Pritzker Prize for AI and Science Research Excellence for work in AI-enabled antibiotic discovery. This is a prize, not trial evidence (MIT News). - AI is accelerating natural product drug discovery and reshaping research in Korea (Chosunbiz). - Thailand eyes status as an AI medical hub (Bangkok Post). - GTH's first-half loss narrowed. A share raise funded a pivot toward BioTech and AI (TradingView). 【Device approvals and regulation】 - Brainomix says biomarker qualification is the next step for its FDA-cleared lung AI software. The software is already cleared. The qualification is a future step and has not been granted (Medtech Insight). - A piece asks whether increasingly smart AI medical gadgets can replace doctors. No regulatory action is cited (Analytics Insight).

Safety, errors and bias

- A column argues medical AI needs more than accuracy and that hospitals need accountability (Korea Biomedical Review). - ISMAI 2026 in Florence will host an international symposium on the safe and responsible use of AI in medicine (pharmaphorum). - Hanmi is partnering with FuriosaAI to localize digital health AI in Korea (Chosunbiz). - Medical AI is moving beyond disease detection and diagnosis to patient care as the "Care AI" era begins (Asia Economy). - Eulji University Medical Center marked its 70th anniversary with AI healthcare innovation from diagnosis to patient care (Health Chosun). 【Research findings (major journals)】 None of the items below comes from a major journal in the headlines. Each is a media report, and the underlying study design is not stated. - A report says ChatGPT surpassed specialized medical tools (The Jerusalem Post). - A primary care AI study is headlined 98 patients, 0 safety stops. It is a small sample (shattered.io). - A piece asks whether AI note-takers cut managers' work or just create more of it. The headline does not clearly concern medicine (economy.ac). - AI was used to discover side effects of the unapproved weight-loss drug retatrutide. The headline gives no evidence stage (MiNDFOOD). - A Hausa-language headline concerns whether Nigeria's electoral commission, INEC, can restore public confidence over an AI voter register ahead of the 2027 election. It is not about medicine (Leadership Hausa).

Japan

- Apollo AI, a hospital AI core system originating at the University of Tokyo, was featured in Monthly Pitch (BRIDGE). - Google opened a research hub to support medical AI adoption (NNA Asia). - Japan's PMDA published guidance on AI use in regulatory activities, clarifying a human-centered principle. This is a guideline, not an approval (Nikkan Yakugyo). - MENTRA added web pre-visit questionnaires, phone call routing, and automatic staff assignment to its psychiatry AI (Medical Tech News). - LSTC, in which Rapidus participates, is working on medical AI using 2-nanometer semiconductors with Fujifilm and Hokkaido University (Nikkei xTECH).

Statements from key figures

No notable developments.